Difference between revisions of "DE Frankfurt Schmoll D"
From Bioblast
Nirschl Lisa (talk | contribs) |
|||
Line 12: | Line 12: | ||
|MiPNetLab=Fischer S, Schlotte V | |MiPNetLab=Fischer S, Schlotte V | ||
|Status=O2k 2009- | |Status=O2k 2009- | ||
|info=[[IOC88]] | |info=[[IOC88]], [[IOC75]], [[IOC60]], [[IOC54]] | ||
|keywords= | |keywords= | ||
}} | }} | ||
== Power-O2k == | == Power-O2k == | ||
* [[DE Frankfurt Sanofi]] | * [[DE Frankfurt Sanofi]] |
Revision as of 11:44, 13 February 2018
DE Frankfurt Schmoll D
O2k-Network Lab | Sanofi-Aventis Deutschland GmbH
R&D TD Metabolism FFM |
---|---|
Address | Industriepark Hoechst
Bldg. H825, Room 243, 65926 |
City | Frankfurt |
State/Prov | |
Country | Germany |
Weblink | |
Contact | Schmoll D |
Team | Fischer S, Schlotte V |
Team previous | |
Status | O2k 2009- |
Oroboros Events | IOC88, IOC75, IOC60, IOC54 |
Topics |
O2k-Publications
Published | Reference | |
---|---|---|
Karusheva 2019 Am J Clin Nutr | 2019 | Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, Bódis K, Bärenz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, Müssig K, Szendroedi J, Roden M (2019) Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. Am J Clin Nutr 110:1098-107. |
O2k-Abstracts
update please